Metavant and Poxel Announce Positive Topline Safety and PK/PD Results of Imeglimin in Patients with Type 2 Diabetes and Chronic Kidney Disease Stages 3b/4
NEW YORK & BASEL, Switzerland & LYON, France--(BUSINESS WIRE)--Jul 9, 2019--
NEW YORK & BASEL, Switzerland & LYON, France--(BUSINESS WIRE)--Jul 9, 2019--